â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”
ðŸ“Š HRP | Hedgefund Research Platform
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

# âš”ï¸ Kill Gate Report â€” 2026-01-31

> Pipeline quality gates â€” automated early termination of underperforming hypotheses

## ðŸ“Š Key Metrics

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ðŸ“‹ Evaluated      â”‚ âœ… Passed         â”‚ âŒ Killed         â”‚ â±ï¸ Time Saved    â”‚
â”‚        8         â”‚        5         â”‚        3         â”‚       4.2h       â”‚
â”‚ hypotheses       â”‚ continue         â”‚ terminated       â”‚ compute          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

## ðŸ¥ System Health

Gate 1: Baseline Beat  [â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘] 75% â— ðŸŸ¡
Gate 2: Sharpe Minimum [â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘] 62% â–² ðŸŸ¡
Gate 3: Drawdown Limit [â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘] 88% â— ðŸŸ¢
Overall Survival       [â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘] 62% â–¼ ðŸŸ¡

## âš”ï¸ Kill Gate Settings

```
  Gate 1: Baseline Beat      Must exceed S&P 500 buy-and-hold Sharpe
  Gate 2: Sharpe Minimum      Sharpe >= 0.50 on walk-forward OOS
  Gate 3: Max Drawdown        Max drawdown <= 20%
  Gate 4: Significance        p-value < 0.05 on returns t-test
```

## ðŸ“‹ Results

| # | Hypothesis | Gate 1 | Gate 2 | Gate 3 | Gate 4 | Verdict |
|---|-----------|--------|--------|--------|--------|---------|
| 1 | HYP-2026-008 | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¢ | âœ… **PASSED** |
| 2 | HYP-2026-009 | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¢ | âœ… **PASSED** |
| 3 | HYP-2026-010 | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¡ | âœ… **PASSED** |
| 4 | HYP-2026-011 | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¡ | ðŸŸ¢ | âœ… **PASSED** |
| 5 | HYP-2026-012 | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¢ | ðŸŸ¢ | âœ… **PASSED** |
| 6 | HYP-2026-007 | ðŸ”´ | ðŸ”´ | ðŸ”´ | ðŸ”´ | âŒ **KILLED** |
| 7 | HYP-2026-013 | ðŸŸ¢ | ðŸ”´ | ðŸŸ¢ | ðŸ”´ | âŒ **KILLED** |
| 8 | HYP-2026-016 | ðŸ”´ | ðŸ”´ | ðŸŸ¢ | ðŸŸ¢ | âŒ **KILLED** |

â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘  â„¹ï¸  3 hypotheses terminated early â€” saving ~4.2 hours of ML training compute  â•‘
â•‘  â„¹ï¸  Kill rate: 37.5% (3 of 8) â€” within normal range (30-50%)                  â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

### ðŸ“ˆ Best Surviving Experiment

```
  Hypothesis:   HYP-2026-008 (RSI mean reversion with regime)
  Model:        XGBoost
  Sharpe:       1.22
  Max DD:       -8.7%
  Win Rate:     56.3%
  p-value:      0.008
```


â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ðŸ“Š **HRP | Hedgefund Research Platform**

ðŸ• 2026-01-31 20:45 ET | ðŸ’° $0.0045 | ðŸ¤– pipeline-orchestrator
